CRISPR Therapeutics Says FDA Grants RMAT Designation To CTX130
(RTTNews) - Biopharmaceutical company CRISPR Therapeutics (CRSP) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to CTX130, the Company's wholly-owned allogeneic CAR T cell therapy targeting CD70, for the treatment of Mycosis Fungoides and Sézary Syndrome (MF/SS).
Established under the 21st Century Cures Act, RMAT designation is a dedicated program designed to expedite the drug development and review processes for promising pipeline products, including genetic therapies.
Similar to Breakthrough Therapy designation, RMAT designation provides the benefits of intensive FDA guidance on efficient drug development.
For More Such Health News, visit rttnews.com
read more
Vertex Pharma Inks Licensing Agreement To Use CRISPR Therapeutics' Gene Editing Technology
Biotechnology company Vertex Pharmaceuticals, Inc. (VRTX) and gene editing company CRISPR Therapeutics, Inc. (CRSP) announced Monday that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics' gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex's hypoimmune cell therapies for type 1 diabetes (T1D).
RTTNews
|
660 days ago
Sensex, Nifty Modestly Higher In Cautious Trade
Indian shares opened on a positive note Thursday as investors cheered a soft U.S. inflation print and upbeat earnings from the likes of JPMorgan Chase, BlackRock, Goldman Sachs and Citigroup.
RTTNews
|
6h 2min ago
Asian Markets A Sea Of Green
Asian stock markets are a sea of green on Thursday, following the broadly positive cues from Wall Street overnight, after data showing a slowdown in the annual rate of core consumer prices growth in the U.S. in December helped ease concerns about US Fed's interest rate trajectory. The currencies in the region also strengthened against the US dollar. Asian Markets closed mostly lower on Wednesday.
RTTNews
|
7h 8min ago
Australian Market Trims Early Strong Gains In Mid-market
The Australian stock market slightly trims early strong gains in mid-market moves on Thursday, reversing the losses in the previous session, following the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving above the 8,300 level, with gains is gold miners, technology and financial stocks.
RTTNews
|
7h 48min ago
Sensex, Nifty Set To Follow Global Peers Higher As US Inflation Cools
Indian shares look set to follow global peers higher on Thursday as investors react to lower-than-expected U.S. core inflation data for December and strong earnings reports from major U.S. banks.
RTTNews
|
7h 48min ago
Thai Shares Tipped To Open In The Green
The Thai stock market on Wednesday ended the two-day losing streak in which it had fallen more than 25 points or 2 percent. The Stock Exchange of Thailand now sits just above the 1,350-point plateau and it's expected to open to the upside again on Thursday.
RTTNews
|
8h 31min ago
Indonesia Stock Market May Add To Its Winnings
The Indonesia stock market on Wednesday ended the two-day slide in which it had slumped more than 130 points or 1.8 percent. The Jakarta Composite Index now sits just beneath the 7,080-point plateau and it may extend its gains on Thursday.
RTTNews
|
9h 1min ago
Further Upside Seen For Hong Kong Stock Market
The Hong Kong stock market has moved higher in consecutive trading days, collecting more than 400 points or 2.1 percent along the way. The Hang Seng Index now sits just beneath the 19,300-point plateau and it may add to its winnings on Thursday.
RTTNews
|
9h 16min ago
